Paxman Financial Statements From 2010 to 2025
| PXMBF Stock | USD 3.50 0.00 0.00% |
Check Paxman AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Paxman AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Paxman financial statements analysis is a perfect complement when working with Paxman AB Valuation or Volatility modules.
Paxman |
Paxman AB Company Return On Equity Analysis
Paxman AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Paxman AB Return On Equity | -0.0254 |
Most of Paxman AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Paxman AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Paxman AB has a Return On Equity of -0.0254. This is 99.89% lower than that of the Healthcare sector and 99.71% lower than that of the Medical Devices industry. The return on equity for all United States stocks is 91.81% lower than that of the firm.
Paxman AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Paxman AB's current stock value. Our valuation model uses many indicators to compare Paxman AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Paxman AB competition to find correlations between indicators driving Paxman AB's intrinsic value. More Info.Paxman AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Paxman AB's earnings, one of the primary drivers of an investment's value.About Paxman AB Financial Statements
Paxman AB stakeholders use historical fundamental indicators, such as Paxman AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Paxman AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Paxman AB's assets and liabilities are reflected in the revenues and expenses on Paxman AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Paxman AB. Please read more on our technical analysis and fundamental analysis pages.
Paxman AB , together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North and South America, Central America, Asia, and Oceania. The company was founded in 1996 and is based in Karlshamn, Sweden. Paxman Ab is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Paxman Pink Sheet
Paxman AB financial ratios help investors to determine whether Paxman Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Paxman with respect to the benefits of owning Paxman AB security.